Novartis OTCs Fit Well With Pharma Core - CFO

Novartis' nutritional and eye care businesses are seen as "farther away" from the company's core pharmaceutical focus going forward, CFO Raymund Breu told a J.P. Morgan CEO conference on building shareholder value April 26.